As of April 2025 Lipocine has a market cap of NZ$28.62 Million. This makes Lipocine the world's 9913th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$28.62 M | -36.59% |
2024 | NZ$45.13 M | 92.47% |
2023 | NZ$23.45 M | -57.71% |
2022 | NZ$55.45 M | -56.71% |
2021 | NZ$0.12 B | 3.47% |
2020 | NZ$0.12 B | 475.4% |
2019 | NZ$21.51 M | -48.91% |
2018 | NZ$42.11 M | -58.98% |
2017 | NZ$0.10 B | 5.83% |
2016 | NZ$97.01 M | -71.85% |
2015 | NZ$0.34 B | 301.28% |
2014 | NZ$85.89 M | -32.46% |
2013 | NZ$0.12 B |
On Apr 26th, 2025 the market cap of Lipocine was reported to be: